ghk-cu & bpc-157 hair foam ghk cu or bpc 157 + BPC 157 – Priority Wellness Health Our GHK-Cu/BPC-157 Peptide Hair Foam

It is not manufactured, labeled, or intended for therapeutic administration, injection into humans or animals, or clinical diagnostic applications

FDA stated it lacked safety-related information for certain other injectable routes, meaning the agency did not have enough information to determine whether harm would occur through those routes

Journal (Journal of Physiology and Pharmacology, Dec 2009, 60 Suppl 7, 191196)

Retatrutide is an investigational peptide drug developed by Eli Lilly that acts as a triple agonist, simultaneously targeting three hormone receptors: glucagon-like peptide-1 (GLP-1), glucose-dependent insulinotropic polypeptide (GIP), and glucagon receptors